Surgical strategy for patients with papillary thyroid carcinoma invading the trachea: a comparison of tracheal sleeve resection with end-to-end anastomosis and window resection with tracheocutaneous fistula.

Papillary thyroid carcinoma (PTC) sleeve resection with end-to-end anastomosis tracheal infiltration window resection with tracheocutaneous fistula

Journal

Gland surgery
ISSN: 2227-684X
Titre abrégé: Gland Surg
Pays: China (Republic : 1949- )
ID NLM: 101606638

Informations de publication

Date de publication:
25 Sep 2023
Historique:
received: 29 05 2023
accepted: 02 09 2023
medline: 16 10 2023
pubmed: 16 10 2023
entrez: 16 10 2023
Statut: ppublish

Résumé

Sleeve resection with end-to-end anastomosis (Procedure A) and window resection with a tracheocutaneous fistula (Procedure B) are the major surgical procedures for patients with papillary thyroid carcinoma (PTC) exhibiting transluminal tracheal invasion. For each procedure, the indications, postoperative course, and treatment results were examined retrospectively. Of 1,456 patients with PTC (maximum tumor diameter >1 cm) who received initial treatment between 1993 and 2013, we reviewed 51 patients. Of these 51 cases, 45 showed full-layer tracheal invasion, and 6 did not reach the tracheal mucosa, but required full-layer tracheal resection. Twenty-four patients underwent Procedure A, and 27 patients underwent Procedure B. Regarding surgical procedure selection, Procedure B was selected significantly more frequently than Procedure A for cases with preoperative recurrent laryngeal nerve (RLN) palsy, tumor invasion of the esophagus, clinical lymph node metastasis, or a large number of resected tracheal rings. Postoperative airway-related complications were not significantly different between the procedures, but decreased with the use of intraoperative neuromonitoring (IONM). The postoperative hospital stay was significantly longer for Procedure B than for Procedure A. In addition, the rate of a permanent postoperative tracheostoma was higher with Procedure B than with Procedure A. Local recurrence-free survival (LRFS) and cause-specific survival (CSS) did not differ significantly between the two procedures. Certain patients may benefit from Procedure A with IONM in terms of a shorter hospital stay and avoiding the need for a permanent tracheostoma. Although Procedure B was indicated for patients with more advanced disease than Procedure A, treatment outcomes were similar.

Sections du résumé

Background UNASSIGNED
Sleeve resection with end-to-end anastomosis (Procedure A) and window resection with a tracheocutaneous fistula (Procedure B) are the major surgical procedures for patients with papillary thyroid carcinoma (PTC) exhibiting transluminal tracheal invasion. For each procedure, the indications, postoperative course, and treatment results were examined retrospectively.
Methods UNASSIGNED
Of 1,456 patients with PTC (maximum tumor diameter >1 cm) who received initial treatment between 1993 and 2013, we reviewed 51 patients. Of these 51 cases, 45 showed full-layer tracheal invasion, and 6 did not reach the tracheal mucosa, but required full-layer tracheal resection. Twenty-four patients underwent Procedure A, and 27 patients underwent Procedure B.
Results UNASSIGNED
Regarding surgical procedure selection, Procedure B was selected significantly more frequently than Procedure A for cases with preoperative recurrent laryngeal nerve (RLN) palsy, tumor invasion of the esophagus, clinical lymph node metastasis, or a large number of resected tracheal rings. Postoperative airway-related complications were not significantly different between the procedures, but decreased with the use of intraoperative neuromonitoring (IONM). The postoperative hospital stay was significantly longer for Procedure B than for Procedure A. In addition, the rate of a permanent postoperative tracheostoma was higher with Procedure B than with Procedure A. Local recurrence-free survival (LRFS) and cause-specific survival (CSS) did not differ significantly between the two procedures.
Conclusions UNASSIGNED
Certain patients may benefit from Procedure A with IONM in terms of a shorter hospital stay and avoiding the need for a permanent tracheostoma. Although Procedure B was indicated for patients with more advanced disease than Procedure A, treatment outcomes were similar.

Identifiants

pubmed: 37842530
doi: 10.21037/gs-23-171
pii: gs-12-09-1167
pmc: PMC10570975
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1167-1178

Informations de copyright

2023 Gland Surgery. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://gs.amegroups.com/article/view/10.21037/gs-23-171/coif). The authors have no conflicts of interest to declare.

Références

Thyroid. 2017 May;27(5):626-631
pubmed: 27597378
Cancer. 2000 Jul 1;89(1):202-17
pubmed: 10897019
Ann Thorac Surg. 2011 Apr;91(4):1101-6; discussion 1106
pubmed: 21440131
Eur J Cardiothorac Surg. 2003 Jan;23(1):1-5
pubmed: 12493495
Cancers (Basel). 2021 Feb 14;13(4):
pubmed: 33672929
Surgery. 2004 Feb;135(2):139-48
pubmed: 14739848
Langenbecks Arch Surg. 2014 Feb;399(2):209-16
pubmed: 24271275
J Thorac Cardiovasc Surg. 1997 Jul;114(1):84-92
pubmed: 9240297
J Thorac Cardiovasc Surg. 2004 Nov;128(5):731-9
pubmed: 15514601
J Thorac Cardiovasc Surg. 1991 Nov;102(5):717-20
pubmed: 1943190
Ann Thorac Surg. 2007 Jun;83(6):1952-9
pubmed: 17532377
Ann Oncol. 2009 Oct;20(10):1728-35
pubmed: 19773250
Am J Surg. 1995 Nov;170(5):467-70
pubmed: 7485734
Eur Respir J. 2018 Feb 14;51(2):
pubmed: 29444919
Gland Surg. 2017 Oct;6(5):574-578
pubmed: 29142850
World J Surg. 2004 Dec;28(12):1204-6
pubmed: 15517489
Acta Otolaryngol. 2009 Dec;129(12):1498-502
pubmed: 19922104
Interact Cardiovasc Thorac Surg. 2008 Apr;7(2):227-30; discussion 230
pubmed: 18216046
Laryngoscope. 2021 Apr;131(4):932-946
pubmed: 32985692
Laryngoscope. 1974 Jun;84(6):940-57
pubmed: 4832376
Eur Arch Otorhinolaryngol. 2016 Jul;273(7):1919-26
pubmed: 26198285
World J Surg. 2012 Jun;36(6):1231-40
pubmed: 22402972
Chirurg. 2011 Feb;82(2):134-40
pubmed: 21153528
Arch Otolaryngol Head Neck Surg. 1997 May;123(5):484-90
pubmed: 9158394
Oncol Lett. 2017 Sep;14(3):2822-2830
pubmed: 28927041
World J Surg. 2017 Jul;41(7):1812-1819
pubmed: 28243696
Acta Otolaryngol. 2009 May;129(5):575-9
pubmed: 18720068

Auteurs

Yukari Inoue (Y)

Department of Otorhinolaryngology and Head and Neck Surgery, Dokkyo Medical University Saitama Medical Center, Saitama, Japan.

Aya Ebina (A)

Department of Endocrine Surgery, Nippon Medical School Graduate School of Medicine, Tokyo, Japan.

Kazuhisa Toda (K)

Division of Head and Neck, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan.

Wataru Shimbashi (W)

Division of Head and Neck, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan.

Keiko Yamada (K)

Division of Ultrasonography, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan.

Hiroki Mitani (H)

Division of Head and Neck, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan.

Yasuhiro Tanaka (Y)

Department of Otorhinolaryngology and Head and Neck Surgery, Dokkyo Medical University Saitama Medical Center, Saitama, Japan.

Iwao Sugitani (I)

Department of Endocrine Surgery, Nippon Medical School Graduate School of Medicine, Tokyo, Japan.
Division of Head and Neck, Japanese Foundation for Cancer Research, Cancer Institute Hospital, Tokyo, Japan.

Classifications MeSH